Core Viewpoint - Pineal Capital Management expresses concerns regarding the slow pace of action by Teladoc's Board and management, which may expose the company to takeover risks due to its current depressed stock valuation. The firm believes that Teladoc's market price does not reflect its true value and long-term prospects [3][5]. Company Overview - Teladoc Health is a leader in virtual healthcare, operating two main segments: Integrated Care and BetterHelp, with a member base exceeding 100 million and a strong balance sheet [4]. Investment Thesis - The investment thesis highlights that Teladoc is currently undervalued, trading at approximately 4.18x 2026 EV/EBITDA and a 14% free cash flow yield. This valuation is attributed to past missteps, including overvalued acquisitions and poor capital allocation [5][9]. Key Issues Identified - Over-valued Acquisitions: The acquisition of Livongo in 2020 was completed at a significant premium and has not delivered expected value, raising questions about the Board's decision-making [5][6]. - Capital Allocation: The company has made several acquisitions totaling $131.6 million, but the impact on earnings remains unclear, and there are concerns about the strategic rationale behind these transactions [6][9]. - Stock Performance: Teladoc's stock has declined over 90% from pre-COVID highs, and there is a call for a stock buyback program to address this undervaluation [9][10]. - Investor Communication: The lack of a clear multi-year business plan and updated investor relations materials has negatively impacted market sentiment [9][10]. Proposed Actions - Cost Efficiencies: Implement further cost-cutting initiatives to enhance margins, particularly as the BetterHelp payor model gains traction [10]. - Major Share Buyback Program: A proposed buyback authorization of over $200 million is deemed feasible given the company's under-levered balance sheet [10]. - Strategic Review: A full review of the business, including the potential separation of Integrated Care and BetterHelp into distinct entities, is suggested to unlock shareholder value [10]. Market Opportunities - Favorable Policy Environment: Legislative changes are expected to enhance reimbursement for telehealth services, driving higher utilization across Teladoc's business segments starting in 2026 [8]. - Mental Health Revenue Potential: Teladoc's mental health platform, including BetterHelp and EAP, generated over $1.1 billion in revenue in 2025, indicating significant growth potential [12][15]. - International Expansion: Teladoc's established brand and infrastructure position it well for replicating its U.S. success in other high-demand markets [18].

Core Viewpoint - Deutsche Bank upgraded Teladoc Health to Buy from Hold with a price target of $11, citing attractive valuation and a credible turnaround strategy for the BetterHelp segment [1] Group 1: Valuation and Market Position - Teladoc shares are currently trading at approximately 4.2 times Deutsche Bank's 2026 EBITDA estimate, one of the lowest multiples in the firm's coverage universe [2] - Such low valuations are typically associated with companies facing existential risks, which Deutsche Bank believes does not apply to Teladoc's expanding Integrated Care segment [2] Group 2: BetterHelp Segment Strategy - The BetterHelp business has been experiencing declines, but management has introduced a strategy to stabilize and grow the segment by shifting from a cash-pay model to insurance-covered therapy services [3] - Demand for insured therapy services is increasing, as evidenced by Universal Health Services' recent acquisition of Talkspace, a competitor in the insured therapy market [4] Group 3: Potential for Value Unlocking - The acquisition of Talkspace suggests a potential upside for Teladoc's current share price, indicating a path for unlocking value in the market [4]

Summary of Teladoc Conference Call Company Overview - **Company**: Teladoc Health - **CEO**: Chuck Divita - **Industry**: Telehealth and Integrated Care Key Points CEO Tenure and Company Performance - Chuck Divita reflects on his two-year tenure, noting both strengths and challenges faced at Teladoc, emphasizing the need for increased strategic focus, operational rigor, and product innovation [4] - The company aims to strengthen its position heading into 2026, particularly focusing on BetterHelp, which constitutes about 40% of revenues [4] CFO Search - The search for a new CFO is ongoing, with a focus on finding a candidate with financial expertise and operational rigor [5] Integrated Care Business Performance - Integrated Care has shown low- to mid-single-digit growth with EBITDA margins in the low double-digit to mid-teens range [6] - The business is transitioning from a subscription-based model to a fee-for-service model, driven by market demand for visit-based arrangements [7][24] - The company has seen good underlying growth in visit revenues, particularly in chronic care, which has experienced enrollment growth [9][8] Membership and Guidance - Teladoc has approximately 100 million members, with a projected low single-digit decline in membership for the year due to external healthcare factors [10][14] - Membership has grown by about 40% since 2020, but challenges such as Medicaid redeterminations and changes in the Affordable Care Act may impact retention [15] Chronic Care Segment - Sequential growth in chronic care enrollment is expected, with opportunities for upselling and engaging new members [17][20] - The company aims to penetrate its existing member base more deeply, particularly in weight management services [21] BetterHelp Business Update - BetterHelp has faced volatility but is expected to stabilize as the company pivots towards insurance coverage, which is anticipated to drive growth [30][31] - The direct-to-consumer cash pay model has seen high drop-off rates, with over 80% of potential users not converting due to cost barriers [34] - The company expects to see increased user engagement and lifetime value as insurance coverage expands [36] Financial Guidance and Debt Management - For fiscal 2026, Teladoc anticipates revenue growth driven by insurance scaling and international growth, with projected insurance revenues of $75 million to $90 million [43] - The company plans to pay down a significant portion of its $1 billion debt due next year, leveraging existing cash and traditional term debt [51][52] Market Position and Competitive Landscape - The company views recent M&A activity in the behavioral health space as validation of the demand for virtual mental health services [39] - Teladoc has a strong market position with over 12,000 clients and a significant data advantage, which is crucial for AI deployment in healthcare [55] AI and Future Outlook - Teladoc is actively investing in AI to enhance engagement and service delivery, leveraging its extensive data to improve clinical interventions [54][56] - The company believes its deep expertise in healthcare and regulatory knowledge creates competitive moats in the telehealth industry [56] Additional Insights - The transition to visit-based revenues is seen as beneficial for service engagement, despite some initial headwinds from the subscription model [25] - The company is focused on operational efficiency and cost management to drive EBITDA results [43]

Core Insights - Teladoc Health, Inc. reported a solid finish for 2025, with consolidated revenue and adjusted EBITDA exceeding guidance for the fourth quarter [3][4] - The company is focused on disciplined execution and performance acceleration, aiming to enhance care delivery and outcomes through product innovation and technology advancements [4] Financial Performance - Fourth Quarter 2025 revenue was $642.3 million, a slight increase from $640.5 million in Fourth Quarter 2024, while Full Year 2025 revenue decreased by 2% to $2,530.0 million from $2,569.6 million in Full Year 2024 [5][10] - Net loss for Fourth Quarter 2025 was $25.1 million, or $0.14 per share, a significant improvement from a net loss of $48.4 million, or $0.28 per share, in Fourth Quarter 2024; Full Year 2025 net loss was $200.3 million, or $1.14 per share, compared to $1,001.2 million, or $5.87 per share, in Full Year 2024 [6][11] - Adjusted EBITDA for Fourth Quarter 2025 was $83.8 million, up 12% year-over-year, while Full Year 2025 adjusted EBITDA decreased by 10% to $281.1 million [7][14] Revenue Breakdown - Access fees revenue in Fourth Quarter 2025 decreased by 4% to $521.6 million, while other revenue increased by 24% to $120.7 million; U.S. revenue decreased by 3% to $517.3 million, and International revenue increased by 19% to $125.0 million [5][10] - For Full Year 2025, access fees revenue decreased by 6% to $2,091.9 million, while other revenue increased by 24% to $438.0 million; U.S. revenue decreased by 4% to $2,071.7 million, and International revenue increased by 12% to $458.2 million [10] Segment Performance - Integrated Care segment revenue increased by 5% to $409.1 million in Fourth Quarter 2025, while BetterHelp segment revenue decreased by 7% to $233.2 million [5][32] - For Full Year 2025, Integrated Care segment revenue increased by 3% to $1,579.6 million, while BetterHelp segment revenue decreased by 9% to $950.4 million [10][32] Cash Flow and Capital Expenditures - Operating cash flow for Full Year 2025 was $294.4 million, flat year-over-year, while free cash flow decreased by 2% to $166.9 million [7][15] - Capital expenditures for Full Year 2025 were $127.5 million, compared to $124.1 million in Full Year 2024 [15] Financial Outlook - For Full Year 2026, the company expects revenue between $2,470 million and $2,587 million, with adjusted EBITDA projected between $266 million and $308 million [18] - The first quarter of 2026 is expected to generate revenue between $598 million and $620 million, with adjusted EBITDA between $50 million and $62 million [19]

Core Insights - Teladoc Health, Inc. (TDOC) is expected to report a fourth-quarter 2025 loss of 19 cents per share on revenues of $633.91 million, with a year-over-year revenue decrease of 1% [1][2][7] Financial Performance - The fourth-quarter earnings estimate has improved by a penny over the past 60 days, indicating a year-over-year improvement of 32.1% in the bottom line [2] - For the full year 2025, the Zacks Consensus Estimate for Teladoc's revenues is $2.52 billion, reflecting a decline of 1.9% year over year, while the EPS estimate is a loss of $1.20, showing an improvement of 79.6% year over year [3] Earnings Expectations - Teladoc has beaten earnings estimates in three of the last four quarters, with an average surprise of 14.5% [3] - The company has an Earnings ESP of 0.00% and a Zacks Rank of 2 (Buy), which does not conclusively predict an earnings beat this time [4] Segment Performance - Integrated Care members are expected to increase by 9.1%, with segment EBITDA rising by 20.9% year over year [7][10] - BetterHelp revenue is projected to decline by 6.2%, with paying users down by 5% in Q4, and the adjusted EBITDA from this segment is expected to fall by 28.9% year over year [9][10] Revenue Breakdown - The Zacks Consensus Estimate for fourth-quarter Access fees revenues indicates a 1.3% year-over-year decline, while U.S. operations are expected to have declined, partially offset by increased revenues from international operations [8] - Overall adjusted EBITDA is expected to be between $73 million and $90 million, with free cash flow for the full year 2025 projected to be between $170 million and $185 million [10]

Transforming how better health happens J.P. Morgan Healthcare Conference January 2026 Safe Harbor This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of ...

Core Viewpoint - The company is preparing to provide guidance for 2026 during the upcoming fourth quarter earnings call in February, indicating a cautious approach to growth projections due to macroeconomic uncertainties in the healthcare sector [1] Segment Summaries Integrated Care - The company anticipates potential low single-digit growth for 2026, reflecting a conservative outlook influenced by various factors including the selling season and broader economic conditions [1] BetterHelp - Further details regarding BetterHelp's performance and growth will be discussed later, suggesting that it is a significant area of focus for the company [1]

Core Insights - Teladoc Health, Inc. (TDOC) shares have decreased by 8.9% following the release of its third-quarter 2025 results, primarily due to a decline in access fee revenues, U.S. revenues, and weaker performance in the BetterHelp segment, although this was partially mitigated by strong international revenue growth and reduced expenses [1] Financial Performance - The adjusted loss per share for Q3 2025 was 21 cents, which was narrower than the Zacks Consensus Estimate of a 26-cent loss but wider than the 19-cent loss from the previous year [2] - Operating revenues fell by 2% year over year to $626.4 million, although this figure exceeded the consensus estimate by 0.2% [2] - Access fee revenues decreased by 6% year over year to $520.9 million, missing the Zacks Consensus Estimate of $534 million [3] - Other revenues increased by 24% year over year to $105.5 million, surpassing the consensus estimate of $91 million [3] Geographical Revenue Breakdown - U.S. revenues totaled $509.8 million, down 5% year over year, falling short of the Zacks Consensus Estimate of $521 million [4] - International revenues rose by 12% year over year to $116.7 million, exceeding the consensus estimate of $105 million [4] Expense Management - Total costs and expenses decreased by 1% year over year to $678.4 million, which was lower than the estimate of $691.4 million, driven by reductions in advertising, marketing, technology, and administrative expenses [5] Segment Performance - The Integrated Care segment's revenues grew by 2% year over year to $389.5 million, beating the consensus estimate [6] - The BetterHelp segment's revenues fell by 8% year over year to $236.9 million, missing the consensus estimate [7] Membership and Visits - Total visits to Teladoc Health reached 4.1 million, a 1% increase year over year, surpassing the consensus estimate of 4 million [8] - U.S. Integrated Care Members increased by 9% year over year to 102.5 million, exceeding the consensus estimate [8] Cash Flow and Financial Position - Cash and cash equivalents at the end of Q3 2025 were $726.2 million, down 44.1% from the end of 2024 [10] - Net cash from operations was $99.3 million, a decrease of 9.9% year over year [11] - Free cash flow dropped by 14% year over year to $67.9 million [11] Future Outlook - For Q4 2025, Integrated Care segment revenues are expected to grow by 1-5.2% year over year, while BetterHelp segment revenues are projected to decline by 8.8-3.8% [12] - Total revenues for Q4 are anticipated to be between $622 million and $652 million [13] - For the full year 2025, total revenues are now expected to be between $2.510 billion and $2.539 billion, with an adjusted EBITDA forecast of $270-$287 million [16]

Core Insights - Teladoc reported revenue of $626.44 million for the quarter ended September 2025, a decrease of 2.2% year-over-year, with an EPS of -$0.21 compared to -$0.19 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $625.02 million by 0.23%, while the EPS surprised positively by 19.23% against the consensus estimate of -$0.26 [1] Financial Performance Metrics - Average Monthly Revenue Per U.S. Integrated Care Member was $1.27, matching analyst estimates [4] - BetterHelp Paying Users totaled 0.38 million, slightly below the estimated 0.39 million [4] - U.S. Integrated Care Members reached 102.5 million, exceeding the average estimate of 102.26 million [4] - Chronic Care Program Enrollment was 1.17 million, slightly above the estimate of 1.16 million [4] Revenue by Segment - Integrated Care revenue was $389.54 million, surpassing the estimate of $388.13 million, reflecting a year-over-year increase of 1.5% [4] - BetterHelp revenue was $236.9 million, below the estimate of $237.7 million, indicating a year-over-year decline of 7.8% [4] - BetterHelp-Other Wellness Services generated $5.1 million, compared to the estimate of $5.28 million, representing an 18.5% year-over-year decrease [4] - BetterHelp-Therapy Services revenue was $231.8 million, slightly below the estimate of $231.99 million, showing a 7.5% decline year-over-year [4] Revenue by Type - Other revenue amounted to $105.53 million, exceeding the estimate of $90.63 million, with a year-over-year increase of 23.8% [4] - Access fees revenue was $520.91 million, below the estimate of $533.92 million, reflecting a 6.2% year-over-year decline [4] Adjusted EBITDA - Adjusted EBITDA for BetterHelp was $3.84 million, significantly lower than the average estimate of $8.46 million [4] - Adjusted EBITDA for Integrated Care was $66.07 million, exceeding the estimate of $59.01 million [4] Stock Performance - Teladoc shares returned +8.2% over the past month, outperforming the Zacks S&P 500 composite's +3.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]